Namibia has exceeded its ”3 by 5” World Health Organisation campaign target
By April 2006 all public hospitals in Namibia were providing antiretroviral drugs. About 24,000 HIV-positive Namibians access their medication through the state – meeting 50 percent of its treatment needs. 52,000 people require anti-AIDS medicines. 90 percent adhere to treatment regimens. The recently renovated modern Communicable Disease Clinic a historically black township of Windhoek treats 8,500 adults and 660 children.
By April 2006 all public hospitals in Namibia were providing antiretroviral drugs. About 24,000 HIV-positive Namibians access their medication through the state – meeting 50 percent of its treatment needs. 52,000 people require anti-AIDS medicines. 90 percent adhere to treatment regimens. The recently renovated modern Communicable Disease Clinic a historically black township of Windhoek treats 8,500 adults and 660 children.
Namibia has become the poster child of global treatment access efforts because it is one of the few countries to have exceeded its target in the World Health Organisation’s (WHO) campaign to put three million people on anti-AIDS drugs by the end of 2005.
When WHO launched the ‘3 by 5’ initiative, not much was expected of the small southern African country, struggling to cope with one of the world’s highest prevalence rates and an overburdened health system. The treatment programme was launched in 2003 and the government has rapidly scaled up treatment since then. By April this year all public hospitals were providing antiretroviral (ARV) drugs. With about 24,000 HIV-positive Namibians accessing the medication through the state, the country is meeting 50 percent of its treatment needs – according to national figures, 52,000 people require anti-AIDS medicines.
“Namibia is doing very well in rolling out ARVs .. in three years [it] has reached impressive numbers of people, and this includes their PMTCT [prevention of mother-to-child transmission] programme,” UNAIDS country coordinator Salvator Niyonzima told IRIN/PlusNews. But it was now time to take a “cold hard look at financial sustainability”, he said, as financing for the treatment programme has largely rested on funding from the Global Fund to fight HIV/AIDS, TB and Malaria, and the US President’s Emergency Plan for HIV/AIDS (PEPFAR).
Another growing concern for activists and healthcare workers is keeping all these people on treatment. Figures for adherence to treatment are still high – 90 percent – but in a country facing high levels of unemployment and alcohol abuse, the government could not afford to be complacent, warned Johan Gamatham, treatment literacy programme officer for Lironga Eparu, an association of people living with HIV/AIDS.
Against all odds
Tucked away in the maze of corridors of Katutura Hospital, in a historically black township of the capital, Windhoek, is the recently renovated modern Communicable Disease Clinic. This HIV/AIDS facility treats 8,500 adults and 660 children, and is viewed as the country’s “centre of excellence”, according to the hospital’s head of internal medicine, Dr Ishmael Katjitae, who also sits on the country’s ARV rollout technical advisory committee. However, the ARV clinic is not an accurate reflection of what was happening in the rest of the country. Most of Namibia’s health facilities serve rural areas and are not as well staffed and equipped, said Dr Angelo Madjarov, who had been working in Oshakati, in the north of the country.
Patients attending the clinic don’t consider themselves any better off. A few kilometres away, in another part of Katutura, a support group run by AIDS Care Trust, a local non-governmental organisation (NGO), is holding its Wednesday meeting. Most of the members access treatment at the hospital. Inevitably, with 64 percent of people accessing ARVs nationally being women, the group is largely made up of unemployed women; and many have brought their children. Martha Aluene, 34, who has appointed herself the group’s spokeswoman, says week in and week out the dominant themes of their discussions are transport and food. “The hospital is too far, and what can we do but walk – we don’t have money for [public] transport, and we don’t have income to buy food.”
Aluene’s seven-year-old daughter is also on treatment. “When you are on this medication you always want to eat, sometimes she [her daughter] will even go to the neighbours and ask for food,” Aluene laughed sheepishly. Her daughter does not know she is HIV-positive and used to pester her, repeatedly asking Aluene when they would stop taking the medicine. “I told her, if we stop, we will die. Now she doesn’t ask me any more. I don’t know how I will tell her. Maybe when she is nine, because she will be able to understand better,” Aluene said.
Poverty and alcohol abuse were widespread problems in the township, said Dr Elenice de Klerk of the hospital. “Our counsellors are making an effort to keep record of the common reasons for defaulting [on treatment], and we know this is one of the major causes.” Shebeens (unlicensed bars) in the country’s townships and informal settlements mushroomed when new and more lenient legislation was passed in 1998, replacing the strict liquor laws of the former apartheid era. Small drinking outlets were legalised, as was the sale of homemade brews like the popular ‘tombo’ and ‘ashipembe’. Aletha Kaposambo, a treatment supporter with Lironga Eparu, commented that with tombo being easily available and cheap, she had encountered many HIV-positive people “who end up stopping their medication and start drinking heavily, because it is the only thing they can do”.
Any interruption in treatment can lead to the HI-virus becoming resistant to the medication, hastening progress towards AIDS. “It’s clear that we need to take a closer look at resistance patterns and treatment adherence,” said UNAIDS country coordinator Salvator Niyonzima, who called for government to strengthen treatment literacy efforts and address food insecurity. Internal migration also made it difficult to track patients, as many attending Katutura’s AIDS clinic had come to Windhoek from rural areas seeking work and often return to their rural homes without their medication, De Klerk said. Dr Angela Mushavi, a paediatrician at the clinic, believed that a more pressing problem was the lack of human capacity in the health sector. “We need to decompress the congestion … it doesn’t bode well for adherence. If people have to wait in long queues to get treated, they might not be willing to come back”.
Despite these obstacles, a lot had been done. “We reached the ‘3 by 5’ target through a joint effort between government, development partners and ordinary HIV-positive Namibians,” said Dr Madjarov. “These people budgeted money for transport and got themselves enrolled on the programmes, even with other concerns on their minds, such as work and money.”